Screener
Jade Biosciences JBIO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 14.3×-17.7× | 21.1×+15.3× | 9×+0.2× | 10.3×+3.8× | 32×+25.4× | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | 0×— | 0×-681× | —— | |
| Per Share | ||||||
| Book value per share | $5.13+119% | $10.60+171% | $4.53+185% | $7.09+2,363,000% | -$26.46-909% | |
| Valuation | ||||||
| Market capitalization | $875.74M+222% | $760.92M— | $281.57M— | $337.83M— | —— | |
| Price / book | 3×+1.4× | 2.3×— | 1.6×— | 1.7×— | —— |
FAQ
- Where do Jade Biosciences's ratios come from?
- Every ratio is computed from Jade Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.